Evidence map›Paper›PMID 37193675›Full record

ArticleSchizophrenia bulletin2023

Turning the Spotlight on Apathy: Identification and Treatment in Schizophrenia Spectrum Disorders.

Siv Hege Lyngstad, John Paul Lyne, Henrik Myhre Ihler, Lisette van der Meer, Ann Færden, Ingrid Melle

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Schizophrenia bulletin, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Siv Hege LyngstadNydalen DPS, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
John Paul LyneDepartment of Psychiatry, Royal College of Surgeons in Ireland, Newcastle Hospital, Wicklow, Ireland.
Henrik Myhre IhlerNORMENT, Division of Mental Health and Addiction, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Lisette van der MeerDepartment of Rehabilitation, Lentis Psychiatric Institute, Zuidlaren, The Netherlands.
Ann FærdenDepartment of Acute Psychiatry, Oslo University Hospital, Oslo, Norway.
Ingrid MelleNORMENT, Division of Mental Health and Addiction, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Oslo University Hospital · NORoyal College of Surgeons in Ireland · IEUniversity of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among negative symptoms, apathy is central to the impairments in real-life functioning in schizophrenia spectrum disorders (SSD). Thus, optimizing treatment for apathy appears key to improve outcomes. In treatment research, however, negative symptoms are typically studied as a unifactorial construct. We, therefore, aim to shed necessary light on the status of apathy identification and treatment in SSD.

Indexed as

ApathySchizophreniaHumansSchizophrenic PsychologyAvolitionbiological treatmentexperiential symptomsnegative symptomspsychosispsychosocial treatment

Identifiers

PMID37193675
PMCPMC10483442
OpenAlexW4376871699

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.